Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPAS1 | Q99814 | 4/20 | 0.58 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.57 |
| ▸ | GHSR | Q92847 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 5/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.47 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5776889 | 0.93 | PTGS2 (0.62) | EPAS1PTGS2MAPTSMN1; SMN2ABCB1 | |
| SCHEMBL5778314 | 0.92 | MAPT (0.59) | EPAS1PTGS2GHSRMAPTPOLB | |
| SCHEMBL5774938 | 0.91 | PTGS2 (0.54) | EPAS1PTGS2GHSRMAPTPOLB | |
| SCHEMBL5777335 | 0.91 | PTGS2 (0.54) | EPAS1PTGS2GHSRMAPTPOLB | |
| SCHEMBL7226352 | 0.89 | PTGS2 (0.58) | EPAS1PTGS2GHSRMAPTSMN1; SMN2 | |
| SCHEMBL5774722 | 0.81 | PTGS2 (0.57) | PTGS2MAPTPOLBSMN1; SMN2ABCB1 | |
| SCHEMBL5773623 | 0.80 | EPAS1 (0.58) | EPAS1PTGS2GHSRMAPTPOLB | |
| SCHEMBL5773731 | 0.80 | PTGS2 (0.51) | PTGS2MAPTPOLBSMN1; SMN2ABCB1 | |
| SCHEMBL5776665 | 0.78 | PTGS2 (0.54) | PTGS2GHSRMAPTPOLBSMN1; SMN2 | |
| SCHEMBL5775020 | 0.76 | PTGS2 (0.51) | PTGS2GHSRMAPTPOLBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1224189-B1 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | LILLY CO ELI (US) | 2006-01-25 | — | — | EP | disclosed |
| US-6670373-B1 | Inhibiting resistant neoplasms where the resistance is conferred by multidrug resistance protein; N-3,4,5-trimethoxyphenyl-3-(3-azidomethyl-isoxazolo(4,5-c) -1,2-dihydro-6-chloro-quinolin-2-on-1-yl)phenylacetamide | ELI LILLY AND COMPANY | 2003-12-30 | — | — | US | disclosed |
| EP-1224189-A2 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2002-07-24 | — | — | EP | disclosed |
| WO-2001027116-A2 | CONDENSED DIHYDROQUINOLINONE DERIVATIVES FOR INHIBITING MRP1 | ELI LILLY AND COMPANY (US) | 2001-04-19 | — | — | WO | disclosed |